| 000 | 01319 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513232940.0 | ||
| 264 | 0 | _c20010405 | |
| 008 | 200104s 0 0 eng d | ||
| 022 | _a0959-8138 | ||
| 024 | 7 |
_a10.1136/bmj.322.7286.594 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKelly, C J | |
| 245 | 0 | 0 |
_aRaised cortisol excretion rate in urine and contamination by topical steroids. _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _cMar 2001 |
||
| 300 |
_a594 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadverse effects |
| 650 | 0 | 4 |
_aCushing Syndrome _xchemically induced |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
| 650 | 0 | 4 | _aFalse Positive Reactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrocortisone _xurine |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aVaginal Creams, Foams, and Jellies _xadverse effects |
| 700 | 1 | _aOgilvie, A | |
| 700 | 1 | _aEvans, J R | |
| 700 | 1 | _aShapiro, D | |
| 700 | 1 | _aWallace, A M | |
| 700 | 1 | _aDavies, D L | |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 322 _gno. 7286 _gp. 594 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.322.7286.594 _zAvailable from publisher's website |
| 999 |
_c11175437 _d11175437 |
||